TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: mWELLCARE:An Integrated mHealth System for the Prevention and Care of Chronic Disease
Brief Summary: Major barriers to controlling cardiovascular diseases (CVDs) in India and elsewhere are: low detection rates, inadequate use of evidence based interventions and low adherence with these interventions. Primary health care is the appropriate setting for improving the prevention and management of these chronic conditions. The investigators will develop and evaluate an innovative mobile health (mHealth) software application -'m-WELLCARE'- which provides a patient health profile, decision support for clinical care, monitoring and feedback for use in Indian Community Health Centers (CHCs). The investigators will conduct this research following the steps proposed by the medical research council (MRC) for evaluation of complex interventions. Technical development of m-WELLCARE will be conducted, user acceptability appraised and potential barriers overcome. m-WELLCARE will be evaluated in CHCs of two states, Haryana and Karnataka. The use made of m-WELLCARE, its impact on patterns of health care received and changes in risk factors achieved will be evaluated.


Options:
A: Arm Label: U-healthcare; Type: EXPERIMENTAL; Interventions: Device: U-healthcare service | Arm Label: SMBG group; Type: ACTIVE_COMPARATOR; Interventions: Device: SMBG group | Arm Label: control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: U-healthcare service; Assigned to Arm(s): U-healthcare | Intervention Type: DEVICE; Name: SMBG group; Assigned to Arm(s): SMBG group
B: Arm Label: mWELLCARE software arm; Type: EXPERIMENTAL; Interventions: Other: mWELLCARE | Arm Label: Usual care arm; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual Care | Intervention Type: OTHER; Name: mWELLCARE; Assigned to Arm(s): mWELLCARE software arm | Intervention Type: OTHER; Name: Usual Care; Assigned to Arm(s): Usual care arm
C: Arm Label: Arm 1; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Arm 2; Type: EXPERIMENTAL; Interventions: Behavioral: Nurse Behavioral intervention with Home BP Telemonitoring | Arm Label: Arm 3; Type: EXPERIMENTAL; Interventions: Behavioral: Nurse Medication Management with Home BP Telemonitoring | Arm Label: Arm 4; Type: EXPERIMENTAL; Interventions: Behavioral: Nurse Combined intervention with Home BP Telemonitoring | Intervention Type: BEHAVIORAL; Name: Nurse Behavioral intervention with Home BP Telemonitoring; Assigned to Arm(s): Arm 2 | Intervention Type: BEHAVIORAL; Name: Nurse Medication Management with Home BP Telemonitoring; Assigned to Arm(s): Arm 3 | Intervention Type: BEHAVIORAL; Name: Nurse Combined intervention with Home BP Telemonitoring; Assigned to Arm(s): Arm 4
D: Arm Label: Home blood pressure telemonitoring; Type: N/A; Interventions: N/A | Arm Label: Conventional blood pressure measurement; Type: N/A; Interventions: N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effects of a 5:2 Diet on Weight Loss and Cardiovascular Risk Factors in Obesity
Brief Summary: A randomized clinical trial comparing the effect on weight reduction and cardiometabolic risk factors of intermittent energy restriction and a isocaloric continuous energy restriction in obese subjects.


Options:
A: Arm Label: Normal Diet; Type: PLACEBO_COMPARATOR; Interventions: Other: Resistance Training, Dietary Supplement: Protein Supplementation | Arm Label: Time-Restricted Feeding; Type: EXPERIMENTAL; Interventions: Other: Resistance Training, Dietary Supplement: Protein Supplementation, Behavioral: Time-Restricted Feeding | Arm Label: Time-Restricted Feeding plus HMB; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Beta-hydroxy beta-methylbutyrate, Other: Resistance Training, Dietary Supplement: Protein Supplementation, Behavioral: Time-Restricted Feeding | Intervention Type: DIETARY_SUPPLEMENT; Name: Beta-hydroxy beta-methylbutyrate; Assigned to Arm(s): Time-Restricted Feeding plus HMB | Intervention Type: OTHER; Name: Resistance Training; Assigned to Arm(s): Normal Diet, Time-Restricted Feeding, Time-Restricted Feeding plus HMB | Intervention Type: DIETARY_SUPPLEMENT; Name: Protein Supplementation; Assigned to Arm(s): Normal Diet, Time-Restricted Feeding, Time-Restricted Feeding plus HMB | Intervention Type: BEHAVIORAL; Name: Time-Restricted Feeding; Assigned to Arm(s): Time-Restricted Feeding, Time-Restricted Feeding plus HMB
B: Arm Label: Alternate Day Fasting and Exercise; Type: EXPERIMENTAL; Interventions: Behavioral: Alternate Day Fasting, Behavioral: Exercise | Arm Label: Alternate Day Fasting; Type: EXPERIMENTAL; Interventions: Behavioral: Alternate Day Fasting | Arm Label: Exercise; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Alternate Day Fasting; Assigned to Arm(s): Alternate Day Fasting, Alternate Day Fasting and Exercise | Intervention Type: BEHAVIORAL; Name: Exercise; Assigned to Arm(s): Alternate Day Fasting and Exercise, Exercise
C: Arm Label: intermittent energy restriction; Type: EXPERIMENTAL; Interventions: Other: dietary intervention intermittent energy restriction | Arm Label: continuous energy restriction; Type: ACTIVE_COMPARATOR; Interventions: Other: continuous energy restriction | Intervention Type: OTHER; Name: dietary intervention intermittent energy restriction; Assigned to Arm(s): intermittent energy restriction | Intervention Type: OTHER; Name: continuous energy restriction; Assigned to Arm(s): continuous energy restriction
D: Arm Label: Alternate day fasting; Type: EXPERIMENTAL; Interventions: Other: Alternate day fasting | Intervention Type: OTHER; Name: Alternate day fasting; Assigned to Arm(s): Alternate day fasting

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluating Individual and Patient-Selected Family/Friend/or Reciprocal Peer Notifications to Improve Statin Medication Adherence Among Patients With Coronary Artery Disease
Brief Summary: The purpose of this research study is to improve statin medication adherence among Veterans with coronary artery disease with poor adherence to medications. The investigators are testing if newer technology pill bottle devices linked with individual feedback and/or social incentive strategies can improve medication taking behavior.


Options:
A: Arm Label: Peer-mentoring; Type: EXPERIMENTAL; Interventions: Other: Peer-mentoring | Intervention Type: OTHER; Name: Peer-mentoring; Assigned to Arm(s): Peer-mentoring
B: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Individual Feedback; Type: EXPERIMENTAL; Interventions: Behavioral: Individual Feedback | Arm Label: Feedback Friend; Type: EXPERIMENTAL; Interventions: Behavioral: Individual Feedback, Behavioral: Feedback Friend | Intervention Type: BEHAVIORAL; Name: Individual Feedback; Assigned to Arm(s): Feedback Friend, Individual Feedback | Intervention Type: BEHAVIORAL; Name: Feedback Friend; Assigned to Arm(s): Feedback Friend
C: Arm Label: Enhanced Usual Care (EUC) exercise group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Enhanced Usual Care Group | Arm Label: HEART Camp (HC) Intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: HEART Camp (HC) Intervention Group | Intervention Type: BEHAVIORAL; Name: Enhanced Usual Care Group; Assigned to Arm(s): Enhanced Usual Care (EUC) exercise group | Intervention Type: BEHAVIORAL; Name: HEART Camp (HC) Intervention Group; Assigned to Arm(s): HEART Camp (HC) Intervention group
D: Arm Label: Lifestyle counselling; Type: EXPERIMENTAL; Interventions: Other: Disease management program | Arm Label: Comparator; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual care | Intervention Type: OTHER; Name: Disease management program; Assigned to Arm(s): Lifestyle counselling | Intervention Type: BEHAVIORAL; Name: Usual care; Assigned to Arm(s): Comparator

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Different Routes of Misoprostol for Same-day Cervical Preparation Prior to First Trimester Surgical Abortion: a Randomized Controlled Trial
Brief Summary: A randomized clinical trial to assess the effectiveness of same-day cervical preparation with oral, buccal or vaginal Misoprostol, given 2-4 hours prior first trimester curettage.


Options:
A: Arm Label: PO Misoprostol; Type: ACTIVE_COMPARATOR; Interventions: Drug: Misoprostol (cytotec) | Arm Label: PV Misoprostol; Type: ACTIVE_COMPARATOR; Interventions: Drug: Misoprostol (cytotec) | Arm Label: Buccal Misoprostol; Type: ACTIVE_COMPARATOR; Interventions: Drug: Misoprostol (cytotec) | Intervention Type: DRUG; Name: Misoprostol (cytotec); Assigned to Arm(s): Buccal Misoprostol, PO Misoprostol, PV Misoprostol
B: Intervention Type: DRUG; Name: Doxycycline; Assigned to Arm(s): N/A
C: Arm Label: sublingual misoprostol; Type: EXPERIMENTAL; Interventions: Drug: sublingual misoprostol | Arm Label: vaginal misoprostol; Type: ACTIVE_COMPARATOR; Interventions: Drug: vaginal misoprostol | Intervention Type: DRUG; Name: sublingual misoprostol; Assigned to Arm(s): sublingual misoprostol | Intervention Type: DRUG; Name: vaginal misoprostol; Assigned to Arm(s): vaginal misoprostol
D: Arm Label: Misoprostol; Type: ACTIVE_COMPARATOR; Interventions: Drug: Misoprostol | Arm Label: Manual vacuum aspiration (MVA); Type: ACTIVE_COMPARATOR; Interventions: Procedure: surgery Manual vacuum aspiration (MVA) | Intervention Type: DRUG; Name: Misoprostol; Assigned to Arm(s): Misoprostol | Intervention Type: PROCEDURE; Name: surgery Manual vacuum aspiration (MVA); Assigned to Arm(s): Manual vacuum aspiration (MVA)

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Early Identification of People at Risk for Sick-leave Due to Work-related Stress - A Randomized Controlled Study of People With Mental Disorders and Physical Complaints Consulting Primary Health Care
Brief Summary: A vital question for society in general and primary health care in particular is early identification of persons at risk of sickness absence due to work-related stress. Even though both the individual and society can gain a lot from the prevention of absence, not the least since return to work is costly once a person is sick-listed. There is, surprisingly enough, no established method to do this. This project is a randomized controlled study of people with mental disorders and physical complaints consulting primary care. The purpose is to evaluate if a systematic use of early identification of work-related stress, combined with feedback at consultation, at the primary health care centers can prevent sickness absence among employed women and men with common mental disorders and subjective physical health complaints.


Options:
A: Arm Label: Intervention Group; Type: EXPERIMENTAL; Interventions: Other: Loop | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Loop; Assigned to Arm(s): Intervention Group
B: Arm Label: Feedback Group; Type: EXPERIMENTAL; Interventions: Other: Feedback Group | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Feedback Group; Assigned to Arm(s): Feedback Group
C: Arm Label: Usual Care Control hospital unit; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: implementation unit; Type: EXPERIMENTAL; Interventions: Other: RN-RHDS protocol, Other: RN-RHDS+PT-RHDS protocol, Other: RN-RHDS + PT-RHDS + NIAF | Intervention Type: OTHER; Name: RN-RHDS protocol; Assigned to Arm(s): implementation unit | Intervention Type: OTHER; Name: RN-RHDS+PT-RHDS protocol; Assigned to Arm(s): implementation unit | Intervention Type: OTHER; Name: RN-RHDS + PT-RHDS + NIAF; Assigned to Arm(s): implementation unit
D: Arm Label: Questionnaire and feedback; Type: OTHER; Interventions: Other: Questionnaire and feedback | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Questionnaire and feedback; Assigned to Arm(s): Questionnaire and feedback

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Growth and Tolerance of Cow's Milk-Based Infant Formulas
Brief Summary: This clinical trial will evaluate the growth, tolerance, and iron status of infants who consume an investigational infant formula containing a nutrient-rich whey protein compared to a previously marketed infant formula.


Options:
A: Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Other: Standard infant formula | Arm Label: Test Product; Type: EXPERIMENTAL; Interventions: Other: Infant formula with different level of proteins | Arm Label: Breast Milk; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Standard infant formula; Assigned to Arm(s): Control | Intervention Type: OTHER; Name: Infant formula with different level of proteins; Assigned to Arm(s): Test Product
B: Arm Label: Standard infant formula; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Standard infant formula | Arm Label: Protein reduced formula; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Protein reduced alpha-lactalbumin formula, with higher levels of alpha-lactalbumin | Arm Label: Breast-feeding; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DIETARY_SUPPLEMENT; Name: Standard infant formula; Assigned to Arm(s): Standard infant formula | Intervention Type: DIETARY_SUPPLEMENT; Name: Protein reduced alpha-lactalbumin formula, with higher levels of alpha-lactalbumin; Assigned to Arm(s): Protein reduced formula
C: Arm Label: Protein formula; Type: EXPERIMENTAL; Interventions: Other: Alternate protein infant formula | Arm Label: Standard infant formula; Type: ACTIVE_COMPARATOR; Interventions: Other: Standard infant formula | Intervention Type: OTHER; Name: Alternate protein infant formula; Assigned to Arm(s): Protein formula | Intervention Type: OTHER; Name: Standard infant formula; Assigned to Arm(s): Standard infant formula
D: Arm Label: Previously marketed infant formula; Type: ACTIVE_COMPARATOR; Interventions: Other: Previously marketed infant formula | Arm Label: Previously marketed formula using a similar protein; Type: EXPERIMENTAL; Interventions: Other: Previously marketed formula using a similar protein | Intervention Type: OTHER; Name: Previously marketed infant formula; Assigned to Arm(s): Previously marketed infant formula | Intervention Type: OTHER; Name: Previously marketed formula using a similar protein; Assigned to Arm(s): Previously marketed formula using a similar protein

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: BRE-WL4AA Moving Forward: A Weight Loss Intervention for African-American Breast Cancer Survivors
Brief Summary: This is a randomized intervention study to examine the effects of the Moving Forward Guided Weigh Loss Intervention compared to a self-guided weight loss program on BMI and behavioral, biological, and psychosocial outcomes in overweight and obese African American women diagnosed with Stage I, II, or III breast cancer.


Options:
A: Arm Label: SG-WLP; Type: OTHER; Interventions: Behavioral: SG-WLP | Arm Label: MF-WLP; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: MF-WLP | Intervention Type: BEHAVIORAL; Name: MF-WLP; Assigned to Arm(s): MF-WLP | Intervention Type: BEHAVIORAL; Name: SG-WLP; Assigned to Arm(s): SG-WLP
B: Arm Label: Lymphedema Care Only; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Exercise only; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise Intervention | Arm Label: Weight loss only; Type: EXPERIMENTAL; Interventions: Behavioral: Weight Loss Intervention | Arm Label: Exercise and Weight loss combined; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise Intervention, Behavioral: Weight Loss Intervention | Intervention Type: BEHAVIORAL; Name: Exercise Intervention; Assigned to Arm(s): Exercise and Weight loss combined, Exercise only | Intervention Type: BEHAVIORAL; Name: Weight Loss Intervention; Assigned to Arm(s): Exercise and Weight loss combined, Weight loss only
C: Arm Label: Exercise; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise | Arm Label: Attention Control (Health Education); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Attention Control (Health Education) | Intervention Type: BEHAVIORAL; Name: Exercise; Assigned to Arm(s): Exercise | Intervention Type: BEHAVIORAL; Name: Attention Control (Health Education); Assigned to Arm(s): Attention Control (Health Education)
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive behavioral therapy CBT) for weight loss | Intervention Type: BEHAVIORAL; Name: Cognitive behavioral therapy CBT) for weight loss; Assigned to Arm(s): 1

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Aneurysmal Subarachnoid Hemorrhage: Red Blood Cell Transfusion and Outcome - A Pilot Randomized Controlled Trial
Brief Summary: The purpose of this study is to determine the feasibility of conducting a large trial examining the effect on clinical outcome of a liberal red blood cell (RBC) transfusion strategy compared to a restrictive strategy (usual care) in patients with aneurysmal subarachnoid hemorrhage (SAH).


Options:
A: Arm Label: Liberal RBC Transfusion Strategy; Type: EXPERIMENTAL; Interventions: Other: Liberal Red Blood Cell Transfusion Strategy | Arm Label: Restrictive RBC Transfusion Strategy; Type: ACTIVE_COMPARATOR; Interventions: Other: Restrictive Red Blood Cell Transfusion Strategy | Intervention Type: OTHER; Name: Liberal Red Blood Cell Transfusion Strategy; Assigned to Arm(s): Liberal RBC Transfusion Strategy | Intervention Type: OTHER; Name: Restrictive Red Blood Cell Transfusion Strategy; Assigned to Arm(s): Restrictive RBC Transfusion Strategy
B: Arm Label: Liberal; Type: EXPERIMENTAL; Interventions: Drug: red blood cell transfusion trigger | Arm Label: Restrictive; Type: ACTIVE_COMPARATOR; Interventions: Drug: red blood cell transfusion trigger | Intervention Type: DRUG; Name: red blood cell transfusion trigger; Assigned to Arm(s): Liberal, Restrictive
C: Arm Label: Restrictive Transfusion Strategy; Type: EXPERIMENTAL; Interventions: Procedure: Transfusion | Arm Label: Liberal Transfusion Strategy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Transfusion | Intervention Type: PROCEDURE; Name: Transfusion; Assigned to Arm(s): Liberal Transfusion Strategy, Restrictive Transfusion Strategy
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Device: Sangvia® System | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Sangvia® System; Assigned to Arm(s): 1

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Aneurysmal Subarachnoid Hemorrhage: Red Blood Cell Transfusion and Outcome - A Pilot Randomized Controlled Trial
Brief Summary: The purpose of this study is to determine the feasibility of conducting a large trial examining the effect on clinical outcome of a liberal red blood cell (RBC) transfusion strategy compared to a restrictive strategy (usual care) in patients with aneurysmal subarachnoid hemorrhage (SAH).


Options:
A: Arm Label: Low transfusion threshold; Type: EXPERIMENTAL; Interventions: Biological: Red blood cell transfusion | Arm Label: High transfusion threshold; Type: ACTIVE_COMPARATOR; Interventions: Biological: Red blood cell transfusion | Intervention Type: BIOLOGICAL; Name: Red blood cell transfusion; Assigned to Arm(s): High transfusion threshold, Low transfusion threshold
B: Arm Label: Liberal RBC Transfusion Strategy; Type: EXPERIMENTAL; Interventions: Other: Liberal Red Blood Cell Transfusion Strategy | Arm Label: Restrictive RBC Transfusion Strategy; Type: ACTIVE_COMPARATOR; Interventions: Other: Restrictive Red Blood Cell Transfusion Strategy | Intervention Type: OTHER; Name: Liberal Red Blood Cell Transfusion Strategy; Assigned to Arm(s): Liberal RBC Transfusion Strategy | Intervention Type: OTHER; Name: Restrictive Red Blood Cell Transfusion Strategy; Assigned to Arm(s): Restrictive RBC Transfusion Strategy
C: Arm Label: Liberal; Type: EXPERIMENTAL; Interventions: Drug: red blood cell transfusion trigger | Arm Label: Restrictive; Type: ACTIVE_COMPARATOR; Interventions: Drug: red blood cell transfusion trigger | Intervention Type: DRUG; Name: red blood cell transfusion trigger; Assigned to Arm(s): Liberal, Restrictive
D: Arm Label: Liberal blood transfusion; Type: ACTIVE_COMPARATOR; Interventions: Biological: SAGM (Saline-Adenine-Glucose-Mannitol) blood transfusion | Arm Label: Restrictive blood transfusion; Type: ACTIVE_COMPARATOR; Interventions: Biological: SAGM (Saline-Adenine-Glucose-Mannitol) blood transfusion | Intervention Type: BIOLOGICAL; Name: SAGM (Saline-Adenine-Glucose-Mannitol) blood transfusion; Assigned to Arm(s): Liberal blood transfusion | Intervention Type: BIOLOGICAL; Name: SAGM (Saline-Adenine-Glucose-Mannitol) blood transfusion; Assigned to Arm(s): Restrictive blood transfusion

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Aneurysmal Subarachnoid Hemorrhage: Red Blood Cell Transfusion and Outcome - A Pilot Randomized Controlled Trial
Brief Summary: The purpose of this study is to determine the feasibility of conducting a large trial examining the effect on clinical outcome of a liberal red blood cell (RBC) transfusion strategy compared to a restrictive strategy (usual care) in patients with aneurysmal subarachnoid hemorrhage (SAH).


Options:
A: Arm Label: Liberal Transfusion Strategy; Type: EXPERIMENTAL; Interventions: Biological: Red blood cell transfusion | Arm Label: Restrictive transfusion strategy; Type: EXPERIMENTAL; Interventions: Biological: Red blood cell transfusion | Intervention Type: BIOLOGICAL; Name: Red blood cell transfusion; Assigned to Arm(s): Liberal Transfusion Strategy, Restrictive transfusion strategy
B: Arm Label: Liberal Group; Type: EXPERIMENTAL; Interventions: Other: Haemoglobin 9.5 g/dL | Arm Label: Restrictive group; Type: ACTIVE_COMPARATOR; Interventions: Other: Haemoglobine 7.5g/dL | Intervention Type: OTHER; Name: Haemoglobin 9.5 g/dL; Assigned to Arm(s): Liberal Group | Intervention Type: OTHER; Name: Haemoglobine 7.5g/dL; Assigned to Arm(s): Restrictive group
C: Intervention Type: DRUG; Name: Red blood cell transfusion; Assigned to Arm(s): N/A
D: Arm Label: Liberal RBC Transfusion Strategy; Type: EXPERIMENTAL; Interventions: Other: Liberal Red Blood Cell Transfusion Strategy | Arm Label: Restrictive RBC Transfusion Strategy; Type: ACTIVE_COMPARATOR; Interventions: Other: Restrictive Red Blood Cell Transfusion Strategy | Intervention Type: OTHER; Name: Liberal Red Blood Cell Transfusion Strategy; Assigned to Arm(s): Liberal RBC Transfusion Strategy | Intervention Type: OTHER; Name: Restrictive Red Blood Cell Transfusion Strategy; Assigned to Arm(s): Restrictive RBC Transfusion Strategy

Answer: D